More recently, Simonds et al. (2014) reported that increased leptin levels in diet-induced obesity drive an increase in blood pressure in rodents, suggesting that pharmacological approaches based on the modulation of leptin effects on specific subpopulations of neurons could represent a potentially useful therapeutic strategy for obesity-associated hypertension and cardiovascular disease. This evidence concerns the gene LEP and hypertensive disorder.